RYTM - Financial Reports List - Rhythm Pharmaceuticals, Inc. - IntrinsicAlpha

Rhythm Pharmaceuticals, Inc. RYTM

Healthcare - Biotechnology - NASDAQ - US

$ 62.61

-2.29 %

$ 3.98 B

Market Cap

-22.29

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	25.94%	64.99%	66.40%
Quarterly Report	Q4	8-K	2024-12-31	72.61%	-3.98%	0.02%
Annual Report	FY	10-K	2024-12-31	68.06%	-41.11%	-44.02%
Quarterly Report	Q3	8-K	2024-09-30	47.76%	-1.83%	0.15%
Quarterly Report	Q2	8-K	2024-06-30	51.28%	30.92%	13.14%
Quarterly Report	Q1	8-K	2024-03-31	126.41%	-172.78%	-166.29%
Quarterly Report	Q4	8-K	2023-12-31	175.70%	2.02%	1.99%
Annual Report	FY	10-K	2023-12-31	227.56%	-0.87%	-2.90%
Quarterly Report	Q3	8-K	2023-09-30	425.30%	-4.02%	-11.93%
Quarterly Report	Q2	8-K	2023-06-30	112.01%	-3.78%	-3.34%

1